Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORPEDO: Toradol and Lyrica in Donor Nephrectomy
NCT03669081Phase 2Completed
- Sponsor
- University of Utah
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Toradol and Lyrica with Placebo and Standard of Care (2 arms). Primary endpoints: Cumulative Narcotic Use at 82.25 hours and Length of Hospital Stay at 82.25 hours. Started Sep 2016; status: completed.
02
Drugs
ketorolacpregabalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03669081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03669081.